OCGN 1.12 (+0%)
US67577C1053BiotechnologyBiotechnology

Ocugen (OCGN) Stock Highlights

1.12 | +0%
2024-09-19 04:47:25
Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotechs COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets.

Statistics

Range Today
1.1 1.18
Volume Today 3.49M
Range 1 Year
0.34 2.11
Volume 1 Year 1.34B
Range 3 Year
0.34 17.65
Volume 3 Year 6.54B
Range 10 Year
0.17 778.2
Volume 10 Year 21.4B

Highlights

Market Capitalization 348.31M (small)
Floating Shares 283.91M
Current Price 1.12
Price To Earnings -6.72
Price To Revenue 46.74
Price To Book 18.33
Earnings Per Share -0.18
Payout Ratio 0%

Performance

Latest 0%
1 Month -11.11%
3 Months -18.25%
6 Months +2.75%
1 Year +173.17%
3 Years -85.01%
5 Years -91.74%
10 Years -99.84%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.